Pheochromocytoma other diagnostic studies

Revision as of 22:04, 28 July 2020 by Ifrah Fatima (talk | contribs) (→‎Other Diagnostic Studies)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Pheochromocytoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pheochromocytoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pheochromocytoma other diagnostic studies On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pheochromocytoma other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pheochromocytoma other diagnostic studies

CDC on Pheochromocytoma other diagnostic studies

Pheochromocytoma other diagnostic studies in the news

Blogs on Pheochromocytoma other diagnostic studies

Directions to Hospitals Treating Pheochromocytoma

Risk calculators and risk factors for Pheochromocytoma other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2] Mohammed Abdelwahed M.D[3]

Overview

Clonidine suppression test may be used in the diagnosis of pheochromocytoma.

Other Diagnostic Studies

Other diagnostic studies for pheochromocytoma include:

References

  1. Goupil R, Fountoulakis S, Gordon RD, Stowasser M (2015). "Urinary clonidine suppression testing for the diagnosis of pheochromocytoma". J Hypertens. 33 (11): 2286–93. doi:10.1097/HJH.0000000000000705. PMID 26335433.